News

JSC Kalceks launches Hydromorphone Kalceks 2, 10, 20 and 50 mg/ml solution for injections/infusions

JSC Kalceks launches Hydromorphone Kalceks 2, 10, 20 and 50 mg/ml solution for injections/infusions

JSC Kalceks starts production and commercialization of Hydromorphone Kalceks 2, 10, 20 and 50 mg/ml solution for injections/infusions. Product has been registered via decentralized registration procedure involving 10 European Union countries. First sales are expected in Germany and Netherlands following by other EU countries. Hydromorphone Kalceks 2, 10, 20 and 50 mg/ml solution for injections/infusions is a third new product that Kalceks launches within this year.

19.06.2019.
JSC Kalceks launches Oxycodone 10 mg/ml and 50 mg/ml solution for injections/infusions

JSC Kalceks launches Oxycodone 10 mg/ml and 50 mg/ml solution for injections/infusions

JSC Kalceks starts production and commercialization of Oxycodone Kalceks 10 mg/ml and 50 mg/ml solution for injections/infusions. Product has been registered via decentralized registration procedure involving 13 European Union countries. First sales are expected in Germany, Netherlands, Latvia, Estonia following by other EU countries. Oxycodone Kalceks 10 mg/ml and 50 mg/ml solution for injections/infusions is a second new product that Kalceks launches within this year.

10.06.2019.
JSC “Kalceks” participated in the international exhibition CPhI Japan 2019 expanding cooperation in Southeast Asia region.

JSC “Kalceks” participated in the international exhibition CPhI Japan 2019 expanding cooperation in Southeast Asia region.

From 18th to 20th of March 2019, representatives of JSC “Kalceks” participated in international exhibition CPhI Japan 2019 in Tokyo with the aim of expanding cooperation opportunities, focusing directly on Southeast Asian market and promoting export of JSC “Kalceks” products to countries such as Japan, China, South Korea, Philippines and Taiwan.

26.03.2019.
JSC “Kalceks” launches Dexketoprofen solution for injections

JSC “Kalceks” launches Dexketoprofen solution for injections

JSC “Kalceks” starts production and commercialization of Dexketoprofen 25 mg/ml 2 ml solution for injections. Product has been recently approved via decentralized registration procedure involving seven European Union countries. First sales are expected in Baltic States – Latvia, Lithuania and Estonia, where it is already available under name Dexketoprofen Kalceks, then in Poland and Bulgaria under brand name Auxilen®, as well as in Romania where it will be commercialized under brand name Xedofen®.

23.05.2018.
JSC “Kalceks” launches B-vitamins complex solution for injections

JSC “Kalceks” launches B-vitamins complex solution for injections

JSC “Kalceks” starts production and commercialization of B-vitamins complex solution for injections. The product has been recently approved via decentralized registration procedure involving ten European Union countries. First sales are expected in Baltic countries, where it is already available under brand name “Neiratax®” and in Poland, where it will be commercialized under brand name “Neiraxin® B”.

19.12.2017.
JSC “Kalceks” starts production of tramadol injections

JSC “Kalceks” starts production of tramadol injections

JSC “Kalceks” announces that the medicine “Tramadol-Kalceks 100mg/2ml solution for injection” has been approved by the State Agency of Medicines of the Republic of Latvia in June, this year. Active substance of the product is tramadol hydrochloride that works in certain areas of the brain and nervous system and is commonly used for treating of moderate to moderately severe pain.

09.06.2016.